Clinical Trial: A single-center, open-label IIT study evaluated the efficacy and safety of tumor electric field therapy combined with gemcitabine and albumin-bound paclitaxel in the treatment of advanced pancreatic cancer (China)

China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A single-center, open-label IIT study evaluated the efficacy and safety of tumor electric field therapy combined with gemcitabine and albumin-bound paclitaxel in the treatment of advanced pancreatic cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131799

Registration Time: 2026/09/07

Type: Interventional study

Primary Sponsor: Fudan University Affiliated Cancer Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=275373

Published by HT Digital Content Services with permission from Health Daily Digest....